The Clinician-Scientist in Vision Science: A Rare and Endangered Species.
The Clinician-Scientist in Vision Science: A Rare and Endangered Species.
复制标题
DOI：
10.1167/tvst.10.1.30
复制
发表时间：
2021-01
影响因子：
3
通讯作者：
Rao RC
中科院分区：
文献类型：
--
作者：
Rao RC
我感谢Van Gelder博士对我们最近在TVST上发表的文章所作的评论。Van Gelder博士是眼科学领域最有成就的内科科学家之一，他的地位和经验为漏出的临床医生-科学家职业管道提供了急需的关注。虽然我几乎同意社论中的每一点，但我想纠正那篇文章中关于我们研究中排除了在国家眼科研究所（NEI）之外获得第二个R01（新的或更新）的临床科学家的声明。事实上，我们确实分析了第二笔R01基金，这些基金是由NEI以外的临床科学家资助的。事实上，我们发现，在那些获得第二个R01的临床科学家中，约10%获得了非nei国家卫生研究所或中心（如国家普通医学科学研究所和国家癌症研究所）资助的R01资助。我们的数据突出了r01资助的眼科和验光临床医生进行的奖学金的多样性。我们的研究结果进一步表明，未来支持跨学科研究的努力可能是维持视觉研究独立职业的战略的一部分。
I thank Dr. Van Gelder for his editorial 1 on our recent article published in TVST. 2 Dr. Van Gelder is one of the most accomplished physician–scientists in ophthalmology, and his stature and experience lend much-needed attention to the leaky clinician–scientist career pipeline. Although I agree with nearly every point in the editorial, I want to correct a statement in that piece regarding an exclusion in our study of clinician–scientists who obtained their second R01 (new or renewal) outside of the National Eye Institute (NEI). In fact, we did analyze second R01 grants awarded to clinician–scientists that were funded outside the NEI. Indeed, we found that, of those clinician–scientists who obtained a second R01,∼ 10% obtained R01 grants funded from a non-NEI National Institutes of Health Institute or Center, such as the National Institute of General Medical Sciences and the National Cancer Institute. Our data highlight the diversity of scholarship conducted by R01-funded clinicians in ophthalmology and optometry. Our findings further suggest that future efforts supporting interdisciplinary efforts may be part of a strategy to sustain independent careers in vision research.
影响因子：
3
作者：
Liu EA;Wang SY;Rao RC
通讯作者：
Rao RC